BF Biosciences Limited
Condensed Interim Statement of Profit or Loss (Un-audited)
For the period ended 30 September 2024
First Quarter ended | |||
30 September | 30 September | ||
2024 | 2023 | ||
-------------------- Rupees -------------------- | |||
Revenue - net | 1,386,371,545 | 964,798,759 | |
Cost of goods sold | (822,538,648) | (586,368,762) | |
Gross profit | 563,832,897 | 378,429,997 | |
Administrative expenses | (11,916,088) | (6,533,305) | |
Selling and distribution expenses | (304,865,314) | (178,574,457) | |
Other expenses | (28,189,471) | (14,391,770) | |
Other income | 2,401,815 | 30,177,088 | |
Profit from operations | 221,263,839 | 209,107,553 | |
Finance cost | (35,028,094) | (41,297,226) | |
Profit before income tax, final tax and | |||
minimum tax differential | 186,235,745 | 167,810,327 | |
Minimum tax differential | (4,159,351) | (3,882,642) | |
Final Tax | (488,651) | (1,181,193) | |
Profit before income tax | 181,587,743 | 162,746,492 | |
Income tax | (66,314,740) | (61,973,115) | |
Profit after taxation | |||
115,273,003 | 100,773,377 | ||
Re-stated | |||
Earnings per share - basic and diluted | 1.82 | 1.59 | |